Abstract: The compositions described herein shift the light output of luciferases to the near-IR by resonance energy transfer to a targetable near-IR fluorophore.
Abstract: Provided herein are enhanced luciferase enzymes for use with thermostable luciferin analogs for bioluminescent assays. In particular, the present disclosure provides compositions, assays, and methods for performing a bioluminescent assay using enhanced, high-activity luciferase enzymes compatible with thermostable luciferins, such as 5,5-disubstituted luciferin analogs.
Type:
Grant
Filed:
June 5, 2019
Date of Patent:
September 26, 2023
Assignee:
Promega Corporation
Inventors:
Michael Killoran, Ce Shi, Mary Hall, Lance P. Encell, Thomas Kirkland
Abstract: Proteins are provided having luciferase activity with lower Km than wild-type luciferases by altering the amino acid residue at position 270 of the wild-type to an amino acid other than glutamate. Greater heat stability than wild-type luciferases while retaining the lower Km is provided by also replacing the glutamate equivalent to that at position 354 of Photinus pyralis luciferase or 356 of Luciola luciferases with an alternative amino acid, particularly lysine and/or the amino acid residue at 215 of Photinus pyralis and 217 of the Luciola species with a hydrophobic amino acid. DNA, vectors and cells that encode for and express the proteins are also provided as are test kits and reagents for carrying out luminescence assays using the proteins of the invention.
Type:
Grant
Filed:
October 1, 1997
Date of Patent:
January 9, 2001
Assignee:
The Secretary of State for Defence in Her Britannic Majesty's
Government of the United Kingdom of Great Britain and Northern
Ireland
Inventors:
David J Squirrell, Christopher R Lowe, Peter J White, James A H Murray
Abstract: Isolated and purified nucleic acid molecules that encode a luciferase from Renilla mulleri, Gaussia and Pleuromamma, and the proteins encoded thereby are provided. Isolated and purified nucleic acids encoding green fluorescent proteins from the genus Renilla and Ptilosarcus, and the green fluorescent proteins encoded thereby are also provided. Compositions and combinations comprising the green fluorescent proteins and/or the luciferase are further provided.
Type:
Grant
Filed:
March 26, 1999
Date of Patent:
May 15, 2001
Assignees:
Prolume, LTD
Inventors:
Bruce J. Bryan, Christopher Szent-Gyorgyi
Abstract: The invention relates to methods and kits for detecting enzyme activity using bioluminescence. In particular, it relates to a novel assay system with increased light yield for a sensitive and convenient detection of luciferase activity, such as luciferase reporter enzyme activity. Provided is a method of detecting luciferase activity in a sample, comprising incubating the sample in the presence of luciferin and ATP to allow the generation of a light signal, wherein said light signal is enhanced by performing the incubation in a reaction mixture comprising phosphate and ammonium ions, and measuring the light signal. The invention also relates to kits for use in such method.
Type:
Grant
Filed:
May 12, 2006
Date of Patent:
September 16, 2008
Assignee:
PerkinElmer Life and Analytical Sciences B.V.
Abstract: The object of the present invention is to provide a detection method and a method of manufacturing a detection kit which are characterized by use of an organic sulfur reagent, are effective at low concentration of the reagent, are inexpensive and have reduced unpleasant odor. Disclosed is a reagent kit for detecting a Coleoptera luciferase, comprising an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion. A method for detecting a Coleoptera luciferase, comprising step 1 of mixing an aqueous solution containing an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion with a sample containing a Coleoptera luciferase to give a mixed solution and step 2 of measuring the light emitted in the mixed solution is also disclosed.
Abstract: The invention relates to methods and kits for detecting enzyme activity using bioluminescence. In particular, it relates to a novel assay system with increased light yield for a sensitive and convenient detection of luciferase activity, such as luciferase reporter enzyme activity. Provided is a method of detecting luciferase activity in a sample, comprising incubating the sample in the presence of luciferin and ATP to allow the generation of a light signal, wherein said light signal is enhanced by performing the incubation in a reaction mixture comprising phosphate and ammonium ions, and measuring the light signal. The invention also relates to kits for use in such method.
Type:
Grant
Filed:
April 8, 2008
Date of Patent:
May 31, 2011
Assignee:
PerkinElmer Life and Analytical Sciences B.V.
Abstract: Luciferases which are different from those known heretofore have been desired. A luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from the group consisting of valine at the position of 44, alanine at the position of 54 and tyrosine at the position of 138 is substituted with other amino acid(s) in the amino acid sequence of SEQ ID NO: 2.
Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
Abstract: The present invention provides a detection method and a method of manufacturing a detection kit, both characterized by use of an organic sulfur reagent, and which are effective at low concentration of the reagent, are inexpensive, and have reduced unpleasent odor. Provided is a reagent kit for detecting a Coleoptera luciferase, comprising an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion. Also provide is a method for detecting a Coleoptera luciferase, comprising step 1 of mixing an aqueous solution, containing an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion, with a sample containing a Coleoptera luciferase, to give a mixed solution; and step 2 of measuring the light emitted in the mixed solution.
Abstract: Luciferase is conjugated to a chemical entity, particularly to a specific binding agent such as an antibody, antigen or a nucleic acid, and more particularly an antibody, by (a) mixing the luciferase with one or more of D-luciferin, magnesium ions and adenosine triphosphate and (b) performing a covalent coupling reaction between the luciferase and the binding reagent using a covalent coupling reagent where the amount of D-luciferin, magnesium ions and/or adenosine triphosphate is sufficient to protect the luciferase activity against inhibition by the covalent coupling reagent. Preferably, step (a) is carried out by mixing the luciferase with its substrates in solution and preferably both magnesium and adenosine triphosphate are present as magnesium adenosine triphosphate (Mg.sup.2+ ATP), optionally together with D-luciferin. Also disclosed is a labeled chemical entity comprising a chemical entity conjugated to active luciferase as formed by the method.
Type:
Grant
Filed:
February 28, 1997
Date of Patent:
November 17, 1998
Assignee:
The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland of Defence Evaluation & Research Agency
Inventors:
David James Squirrell, Melanie Jane Murphy
Abstract: An object of the present invention is to produce a luminescent probe that has less biological effects, efficiently emits visible to near-infrared light, which is excellent for the imaging of individuals, and the use thereof. The present invention provides a sugar chain-containing-luciferase derivative, wherein an organic fluorescent dye is bonded to the luciferase through the sugar chain.
Type:
Grant
Filed:
August 7, 2008
Date of Patent:
March 27, 2012
Assignee:
National Institute of Advanced Industrial Science and Technology
Abstract: The present invention relates generally to methods to monitor the transport of proteins through the secretory pathway, and methods to monitor ER stress. In particular, the present invention relates to methods to monitor, in real-time, the processing of protein through the secretory pathway, which can be monitored both at a subcellular level by florescence visualization and quantitatively by detecting the secreted luciferase reporter protein. The present invention also relates to methods to assess biological processes in cells, in particular the secretory pathway and ER stress, as well as methods to identify agents which augment or inhibit the secretory pathway and/or ER stress. The present invention also relates to compositions and nucleic constructs encoding a secreted luciferase-fluorescent protein conjugate for methods to monitor protein trafficking in the cell by simultaneous detection of fluorescence and luciferase secretion.
Type:
Application
Filed:
October 12, 2007
Publication date:
February 11, 2010
Applicant:
THE GENERAL HOSPITAL CORPORATION
Inventors:
Bakhos A. Tannous, Xandra Breakefield, Jeffrey W. Hewett
Abstract: The invention relates to a bioactive substance labeled with Cypridina luciferase and a quantum dot, the bioactive substance being at least one species selected from the group consisting of antibodies, peptides, organic compounds, hormones, enzyme substrates, sugar chains and nucleic acids.
Type:
Application
Filed:
March 26, 2008
Publication date:
October 2, 2008
Applicant:
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
Abstract: The present invention relates to bacterial luciferase expression cassettes suitable for conferring bioluminescence properties on Gram-positive bacteria, cells transformed with such cassettes, and methods of making and using such cassettes.
Type:
Grant
Filed:
September 7, 2000
Date of Patent:
May 18, 2004
Assignee:
Xenogen Corporation
Inventors:
Kevin P. Francis, Pamela R. Contag, Danny J. Joh
Abstract: Disclosed herein is a method for significantly enhancing the luciferase activity in a chemiluminescence assay technique. The disclosed method involves the use of trehalose, a-D-glucopyranosyl-a-D-glucopyranoside, in a chemiluminescent reactant system. By adding trehalose up to its saturation solubility level, increases in emission intensity of from 25-100%, or greater, can be attained.
Abstract: Enzymes and methods suitable for assaying ATP, and specific application for such assays are described and claimed. In particular, there is described a recombinant mutant luciferase having a mutation for example, in the amino-acid corresponding to amino acid residue number 245 in Photinus pyralis, is such that the Km for ATP of the luciferase is increased e.g. five-fold with respect to that of the corresponding non-mutated enzyme such that it is of the order of 500 &mgr;m-1 mM. Also disclosed are luciferases having additional mutations conferring improved thermostability or altered wavelength of emitted light. Recombinant polynucleotides, vectors and host cells are also disclosed, as are methods of assaying the amount of ATP in a material (e.g. cells) optionally in real-time. Also disclosed are test-kits for in vitro assays.
Type:
Grant
Filed:
August 25, 1999
Date of Patent:
July 24, 2001
Assignee:
The United States of America as represented by the Secretary
of the State of Defence
Inventors:
David James Squirrell, Peter John White, Christopher Robin Lowe, James Augustus Henry Murray